SEC Form 3 · accession 0001209191-19-009101
ACHILLION PHARMACEUTICALS INC · ACHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Di Donato
Officer — Chief Financial Officer
Period of report
Feb 11, 2019
Accepted (ET)
Feb 11, 2019 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No securities are beneficially owned | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
See Exhibit 24.1 Power of Attorney